ABSTRACT
Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact in disease management of malignant melanoma. Sentinel lymph node biopsy determines the nodal stage of the disease and invasion of the sentinel lymph node is the most important prognostic factor. In parallel to the latest technological developments in the recent years, novel hybrid imaging modalities such as SPECT/CT as well as intraoperative gamma cameras and hybrid detectors have been introduced. This procedure guideline is aimed to inform especially nuclear medicine physicians about the methods for detection of sentinel lymph nodes in malignant melanoma patients as well as to provide the state of art technique suitable for local standards in accordance with the current literature.
References
1Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2013;63:11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
2Russak JE, Rigel DS. Risk factors for the development of primary cutaneous melanoma. Dermatol Clin 2012;30:363-368.
3Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491-9; discussion 499-501.
4Snow H. Melanotic cancerous disease. Lancet 1892;2:872-874.
5Lens MB, Dawes M, Goodacre T, Newton-Bishop JA. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials.Arch Surg 2002;137:458-461.
6Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
7Nieweg OE, Tanis PJ, Kroon BB. The definition of a sentinel node. Ann Surg Oncol 2001;8:538-54111.
8Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003;44:570-582.
9Statius Muller MG, Hennipman FA, van Leeuwen PA, Pijpers R, Vuylsteke RJ, Meijer S. Unpredictability of lymphatic drainage patterns in melanoma patients. Eur J Nucl Med Mol Imaging 2002;29:255-261.
10Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-983.
11Morton DL, Thompson JF, Cochran AJ, et al. MSLT Group. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014;370:599-609.
12Morton DL, Cochran AJ, Thompson JF, et al. Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302-311; discussion 311-313.
13Gannon CJ, Rousseau DL Jr, Ross MI, et al. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Cancer 2006;107:2647-2652.
14Mitteldorf C, Bertsch HP, Jung K, et al. Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor. Ann Surg Oncol 2014;21:2252-2258.
15Kretschmer L, Sahlmann CO, Bardzik P, et al. Individualized surgery: gamma-probe-guided lymphadenectomy in patients with clinically enlarged lymph node metastases from melanomas. Ann Surg Oncol 2013;20:1714-1721.
16Smith VA, Lentsch EJ. Sentinel node biopsy in head and neck desmoplastic melanoma: an analysis of 244 cases. Laryngoscope 2012;122:116-120.
17Papeš D, Altarac S, Arslani N, Rajković Z, Antabak A, Ćaćić M. Melanoma of the glans penis and urethra. Urology 2014;83:6-11.
18Ahmed MM, Moore BA, Schmalbach CE. Utility of head and neck cutaneous squamous cell carcinoma sentinel node biopsy: a systematic review. Otolaryngol Head Neck Surg 2014;150:180-187.
19Hruby G, Guminski A, Thompson JF. Management of regional lymph nodes in patients with merkel cell carcinoma following a positive sentinel node biopsy: less may be more, but is either enough? Ann Surg Oncol 2019;26:315-317.
20Andtbacka RH, Donaldson MR, Bowles TL, et al. Sentinel lymph node biopsy for melanoma in pregnant women. Ann Surg Oncol 2013;20:689-696.
21Howman-Giles R, Shaw HM, Scolyer RA, et al. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann Surg Oncol 2010;17:138-143.
22Veenstra HJ, Wouters MW, Kroon BB, Olmos RA, Nieweg OE. Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration. J Surg Oncol 2011;104:454-457.
23Bozkurt MF. Sentinel lymph node imaging and lymphatic mapping. Nucl Med Semin 2016;2:42-48.
24Chakera AH, Lock-Andersen J, Hesse U, et al. One-day or two-day procedure for sentinel node biopsy in melanoma? Eur J Nucl Med Mol Imaging 2009;36:928-937.
25Bluemel C, Herrmann K, Giammarile F, et al. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging 2015;42:1750-1766.
26Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol 2007;14:913-921.
27Gommans GM, van Dongen A, van der Schors TG, et al. Further optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling. Eur J Nucl Med 2001;28:1450-1455.
28Elsinga P, Todde S, Penuelas I, et al. Radiopharmacy Committee of the EANM. Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2010;37:1049-1062.
29Zender C, Guo T, Weng C, Faulhaber P, Rezaee R. Utility of SPECT/CT for periparotid sentinel lymph node mapping in the surgical management of head and neck melanoma. Am J Otolaryngol 2014;35:12-18.
30Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 2003;33:205-218.
31Vermeeren L, Valdés Olmos RA, Klop WM, et al. SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck 2011;33:1-6.
32Estourgie SH, Nieweg OE, Valdés Olmos RA, Hoefnagel CA, Kroon BB. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681-688.
33Wendler T, Hartl A, Lasser T, et al. Towards intra-operative 3D nuclear imaging: reconstruction of 3D radioactive distributions using tracked gamma probes. Med Image Comput Comput Assist Interv 2007;10:909-917.
34Tuncel M, Salancı B, Bozkurt MF. Sentinel lymph node biopsy: current approaches. Nucl Med Semin 2017;3:78-88.
35Frontado LM, Brouwer OR, van den Berg NS, et al. Added value of the hybrid tracer indocyanine green-99mTc-nanocolloid for sentinel node biopsy in a series of patients with different lymphatic drainage patterns. Rev Esp Med Nucl Imagen Mol 2013;32:227-233.
36van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma. Br J Dermatol 2013;168:93-98.
37Blessing K, Sanders DS, Grant JJ. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998;32:139-146.
38van Akkooi AC, Spatz A, Eggermont AM, Mihm M, Cook MG. Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden. Eur J Cancer 2009;45:2736-2742.
39Govindarajan A, Ghazarian DM, McCready DR, Leong WL. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 2007;14:906-912.
40Waddington WA, Keshtgar MR, Taylor I, Lakhani SR, Short MD, Ell PJ. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med 2000;27:377-391.
41Alazraki N, Glass EC, Castronovo F, Olmos RA, Podoloff D. Society of Nuclear Medicine. Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0. J Nucl Med 2002;43:1414-1418.
42Law M, Ma WH, Leung R, et al. Evaluation of patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a phantom study with SPECT/CT and ICRP-103 recommendations. Eur J Radiology 2012;81:e717-e720.
43Lloyd MS, Topping A, Allan R, Powell B. Contraindications to sentinel lymph node biopsy in cutaneous malignant melanoma. Br J Plast Surg 2004;57:725-727.
44ICRP Publication 60:1990 Recommendations of the ICRP. Ann ICRP 1991;21:1-3.
45Sera T, Mohos G, Papos M, et al. Sentinel node detection in malignant melanoma patients: radiation safety considerations. Dermatol Surg 2003;29:141-145.
46Sondak VK, King DW, Zager JS, et al. Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol 2013;20:680-688.
47Thill M, Kurylcio A, Welter R, et al. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast 2014;23:175-179.
